Scarica l'app Stockscreener
5.33
3.70%
0.19
Pre-mercato:
5.32
-0.010
-0.19%
Precedente Chiudi:
$5.14
Aprire:
$5.17
Volume 24 ore:
253.96K
Relative Volume:
0.36
Capitalizzazione di mercato:
$191.07M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+14.87%
1M Prestazione:
-13.19%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$4.83
$5.38
Intervallo di 1 settimana:
$4.40
$5.38
Portata 52W:
$3.85
$26.62
Bioage Labs Inc Stock (BIOA) Company Profile
Nome
Bioage Labs Inc
Settore
Telefono
510-806-1445
Indirizzo
1445A SOUTH 50TH STREET, RICHMOND
Confronta BIOA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIOA
Bioage Labs Inc
|
5.33 | 191.07M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-10 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2024-12-09 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-09 | Downgrade | Jefferies | Buy → Hold |
| 2024-10-21 | Iniziato | Citigroup | Buy |
| 2024-10-21 | Iniziato | Jefferies | Buy |
| 2024-10-21 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Bioage Labs Inc Borsa (BIOA) Ultime notizie
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming DeadlinesBIOA - PR Newswire
BIOA Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges BIOA Investors with Losses to Contact the Firm - GlobeNewswire
BIOA DEADLINE NOTICE: BioAge Labs Investors are Reminded of March 10 Class Action Deadline – Contact BFA Law if You Lost Money (NASDAQ:BIOA) - GlobeNewswire Inc.
Investors in BioAge Labs, Inc. Should Contact Levi & Korsinsky B - GuruFocus.com
BioAge Labs (BIOA) Faces Securities Class Action On Behalf - GlobeNewswire
2025-01-20 | BIOA DEADLINE: The March 10 BioAge Labs Class Action Deadline is ApproachingContact BFA Law if You Suffered Losses | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Longview News-Journal
The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA - PR Newswire
BIOA LEGAL NEWS: A Class Action has been Filed Against - GlobeNewswire
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
ROSEN, A RESPECTED AND LEADING FIRM, Encourages BioAge Labs, Inc. Investors to Secure Counsel - The Bakersfield Californian
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - Markets Insider
BIOA INVESTOR ALERT: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
BioAge Labs, Inc. Class Action Notice: Robbins LLP Reminds - GlobeNewswire
2025-01-17 | BIOA LEGAL ALERT: BioAge Labs Sued after Stock Drops 76%Investors with Losses are Urged to Contact BFA Law before March 10 Class Action Deadline | NDAQ:BIOA | Press Release - Stockhouse Publishing
Deadline Alert: BioAge Labs, Inc. (BIOA) Investors Who Lost - GlobeNewswire
Faruqi & Faruqi Reminds BioAge Investors of the Pending - GlobeNewswire
BioAge Labs, Inc. Class Action: Levi & Korsinsky Reminds BioAge - GuruFocus.com
BioAge Labs, Inc. Class Action: Levi & Korsinsky Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA - Morningstar
Kirby McInerney LLP Reminds BioAge Labs, Inc. (BIOA) - GlobeNewswire
Levi & Korsinsky Reminds BioAge Investors of the Pending - GlobeNewswire
DEADLINE ALERT for RVNC, REGN, and BIOA: The Law Offices of - GlobeNewswire
BioAge Labs, Inc. Sued for Securities Law ViolationsContact T - GuruFocus.com
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Investors who lost money on BioAge Labs, Inc.(BIOA) should - GlobeNewswire
2025-01-15 | BioAge Labs, Inc. Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the BIOA Class Action | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA SHAREHOLDER ALERT: BFA Law Reminds BioAge Labs, Inc. - GlobeNewswire
Class Action Announcement for BioAge Labs, Inc. (BIOA): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against BioAge Labs, Inc. - PR Newswire
BIOA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
2025-01-14 | BIOA SHAREHOLDER NEWS: BFA Law Announces that a Class Action has been filed against BioAge Labs, Inc.Contact the Firm if You Suffered Losses | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against BioAge Labs, Inc. - Business Wire
Shareholders that lost money on BioAge Labs, Inc.(BIOA) should c - GuruFocus.com
Shareholders that lost money on BioAge Labs, Inc.(BIOA) should contact Levi & Korsinsky about pending Class ActionBIOA - Morningstar
BIOA Shareholder Alert: Shareholder Rights Law Firm Robbins - GlobeNewswire
BIOA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
BIOA LAWSUIT ALERT: Levi & Korsinsky Notifies BioAge Labs, - GlobeNewswire
Novartis & BioAge Team Up To Develop Aging Therapies And Boost Investor Potential (BIOA) - Seeking Alpha
Law Offices of Frank R. Cruz Encourages BioAge Labs, Inc. (BIOA) Investors to Inquire About Securities Fraud Class Action - Business Wire
BIOA CLASS ACTION NEWS: BioAge Labs, Inc. Investors are - GlobeNewswire
BioAge Labs, Inc. Securities Fraud Class Action Lawsuit Pending: - GuruFocus.com
BIOA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BIOA - AccessWire
BIOA INVESTOR NOTICE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
BIOA INVESTOR NOTICE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
BIOA CLASS ACTION ALERT: BioAge Labs Investors that Lost - GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - Newsfile
Bioage Labs Inc Azioni (BIOA) Dati Finanziari
Non sono disponibili dati finanziari per Bioage Labs Inc (BIOA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
2.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):